Libo Sun
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
Papers in
- Immunology 11
- Psoriasis: Treatment and Pathogenesis 4
- interferon and immune responses 3
- IL-33, ST2, and ILC Pathways 2
- Immunotherapy and Immune Responses 2
- Immune cells in cancer 2
- Immune Cell Function and Interaction 2
- Co-authors
- Yang Sun (8 shared papers)Fangzhou Lou (9 shared papers)Zhikai Wang (9 shared papers)Zhenyao Xu (8 shared papers)Hong Wang (7 shared papers)Hong Zhou (7 shared papers)Qianqian Yin (7 shared papers)Xiaojie Cai (8 shared papers)
In The Last Decade
Libo Sun
13 papers receiving 302 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 120
- Immunology 78
- Molecular Biology 196
- Dermatology 17
- Oncology 42
Countries citing papers authored by Libo Sun
This map shows the geographic impact of Libo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Sun more than expected).
Fields of papers citing papers by Libo Sun
This network shows the impact of papers produced by Libo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Sun. The network helps show where Libo Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 144 | |
| 2 | 2023 | 32 | |
| 3 | 2020 | 31 | |
| 4 | 2019 | 22 | |
| 5 | 2000 | 19 | |
| 6 | 2022 | 19 | |
| 7 | 2004 | 15 | |
| 8 | 2024 | 11 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 5 | |
| 11 | 2025 | 2 | |
| 12 | 2024 | 1 | |
| 13 | Cryopreservation of tissue cultures of Onobrychis viciifolia and their ultrastructural observation. | 1990 | 1 |
About Libo Sun
Libo Sun is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 13 papers that have together received 307 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (4 papers), interferon and immune responses (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Cancer-related molecular mechanisms research (3 papers), IL-33, ST2, and ILC Pathways (2 papers), Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (120 citations), Immunology (78 citations), Molecular Biology (196 citations), Dermatology (17 citations) and Oncology (42 citations). Libo Sun has collaborated with scholars based in China, Thailand and Japan. Frequent co-authors include Yang Sun, Fangzhou Lou, Zhikai Wang, Zhenyao Xu, Hong Wang, Hong Zhou, Qianqian Yin, Xiaojie Cai, Jing Bai and Linjiao Chen. Their work appears in journals such as Nature Communications, The Journal of Immunology, Genes & Diseases, Biomedicine & Pharmacotherapy and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.